Zheng Li
Research Subjects
Zheng Li has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Binle Tian
Department of Medical Oncology, Cancer Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
25 shared publications - Fan Wang
Cancer Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
25 shared publications - Guo-Huang Fan
Excecutive Office, Immunophage Biotech Co., Ltd., Shanghai, China
25 shared publications - JianFei Wang
Excecutive Office, Immunophage Biotech Co., Ltd., Shanghai, China
25 shared publications - Jianbei Xi
Department of Medicinal Chemistry, Immunophage Biotech Co., Ltd., Shanghai, China
25 shared publications - Jiang Long
Department of Pancreatic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
25 shared publications
Latest Publications
- Open Access
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure.4 from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
A 32-day repeated dose toxicity study of IPG1576 in SD rats.
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure.4 from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
A 32-day repeated dose toxicity study of IPG1576 in SD rats.
- Open Access
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure.5 from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
Effects of IPG1576 on the appearance of the spleen and the splenic immune cells.
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure.5 from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
Effects of IPG1576 on the appearance of the spleen and the splenic immune cells.
- Open Access
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure.2 from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
MDSCs were significantly increased in pancreatic cancer mice and suppressed the proliferation of CD8+ T cells.
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure.2 from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
MDSCs were significantly increased in pancreatic cancer mice and suppressed the proliferation of CD8+ T cells.
- Open Access
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table.4 from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
The effect of IPG1576 in SD rats.
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table.4 from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
The effect of IPG1576 in SD rats.
- Open Access
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table.2 from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
Primer sequences for quantitative real-time PCR
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table.2 from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
Primer sequences for quantitative real-time PCR
- Open Access
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure Legend from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
Supplementary figure legend of supplementary figure 1 to 6.
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure Legend from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
Supplementary figure legend of supplementary figure 1 to 6.
- Open Access
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table.3 from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
Chemical potency, physiochemical properties, and mouse pharmacokinetic data of IPG1576.
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table.3 from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
Chemical potency, physiochemical properties, and mouse pharmacokinetic data of IPG1576.
- Open Access
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure.5 from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
Effects of IPG1576 on the appearance of the spleen and the splenic immune cells.
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure.5 from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
Effects of IPG1576 on the appearance of the spleen and the splenic immune cells.
- Open Access
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table.3 from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
Chemical potency, physiochemical properties, and mouse pharmacokinetic data of IPG1576.
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table.3 from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
Chemical potency, physiochemical properties, and mouse pharmacokinetic data of IPG1576.
- Open Access
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure.6 from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
The effect of IPG1576 on other immune cells in TME.
- 3 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure.6 from The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
The effect of IPG1576 on other immune cells in TME.